CardiAQ's mitral valve performs well in preclinical study

10/1/2009 | Clinica (subscription required)

CardiAQ Valve Technologies' transcatheter mitral valve implantation tool enabled doctors to accurately place the implantable valve relative to the mitral valve annulus as well as securely anchor the implantable device to the mitral anatomy without depending on radial force, according to preclinical trials. The TMVI system treats mitral valve regurgitation by implanting a mitral valve inside a beating heart with the aid of a catheter.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA